Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Amgen Inc.

Start price
Target price
Perf. (%)
€246.80
19.09.23
€250.00
19.09.24
4.13%
27.09.23

Could be worthwhile Investment >10% per year
High dividend yield expected
positive Cash Flow expected
Good rating
buy
Amgen Inc.

Start price
Target price
Perf. (%)
€228.00
20.09.22
€270.00
20.09.23
11.84%
21.09.23

buy
Abbott Laboratories

Start price
Target price
Perf. (%)
€103.36
19.09.22
€130.00
19.09.23
-8.59%
20.09.23

Could be worthwhile Investment >10% per year
High dividend yield expected
Revenue growth >5% per year expected
Top 10 in its market
buy
Amgen Inc.

Start price
Target price
Perf. (%)
€247.05
26.12.22
€255.00
26.12.23
-0.10%
19.09.23

Could be worthwhile Investment >10% per year
High dividend yield expected
positive Cash Flow expected
Good rating
buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€555.50
15.09.23
€558.00
15.09.24
-3.96%
19.09.23

Higher EBIT margin than peer group
Differentiated customer and product portfolio
Medium risks for its business
Top 10 in its market
buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€64.59
16.09.22
-
16.09.23
9.92%
16.09.23

buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€309.00
15.09.22
€550.00
15.09.23
74.76%
16.09.23

buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€502.50
17.08.23
€510.00
17.08.24
10.75%
13.09.23

Higher EBIT margin than peer group
Differentiated customer and product portfolio
Medium risks for its business
Top 10 in its market
buy
Hologic Inc.

Start price
Target price
Perf. (%)
€69.65
22.12.22
-
22.12.23
-0.67%
24.08.23

buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€64.74
22.08.22
€80.00
22.08.23
8.80%
23.08.23

Could be worthwhile Investment >10% per year
Fair valuation
High dividend yield expected
buy
Johnson & Johnson

Start price
Target price
Perf. (%)
€152.60
24.07.23
€155.00
24.07.24
3.47%
16.08.23

High dividend yield expected
positive Cash Flow expected
Good rating
Standard Investments for future growth
buy
Sarepta Therapeutics

Start price
Target price
Perf. (%)
€106.80
16.08.22
-
16.08.23
-2.62%
16.08.23

buy
BioMarin Pharmaceutical Inc.

Start price
Target price
Perf. (%)
€94.03
16.08.22
-
16.08.23
-11.99%
16.08.23

buy
Zoetis Inc. A

Start price
Target price
Perf. (%)
€176.92
03.08.22
€190.00
03.08.23
-6.34%
03.08.23

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Future proof or reliable business model
buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€49.74
20.07.22
€55.00
20.07.23
-33.55%
21.07.23

Small challenges to pay loans and raise capital
Innovative
Very small cyclical dependencies
Some uniques
buy
Johnson & Johnson

Start price
Target price
Perf. (%)
€175.60
13.07.22
€168.00
13.07.23
-19.13%
13.07.23

buy
Becton, Dickinson & Co.

Start price
Target price
Perf. (%)
€235.25
13.07.22
€239.00
13.07.23
-1.59%
13.07.23

buy
Humana Inc.

Start price
Target price
Perf. (%)
€469.25
07.07.22
-
07.07.23
-14.35%
07.07.23

buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€35.70
22.05.23
€50.00
22.05.24
1.68%
08.06.23

Capable Management
Good culture
Innovative
Differentiated customer and product portfolio
buy
AbbVie Inc.

Start price
Target price
Perf. (%)
€137.98
05.06.22
€155.00
05.06.23
-7.09%
06.06.23

Could be worthwhile Investment >10% per year
buy
Regeneron Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€485.05
23.11.20
€770.00
07.07.23
39.47%
25.05.23

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
ROE higher than 15% per year
Pfizer Inc.

Start price
Target price
Perf. (%)
€33.95
22.05.23
€50.00
31.07.23
5.15%
22.05.23

Capable Management
Good culture
Innovative
Differentiated customer and product portfolio
buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€49.24
31.07.22
€50.00
31.07.23
-31.05%
22.05.23

Capable Management
Good culture
Innovative
Differentiated customer and product portfolio
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€78.68
28.10.22
-
28.10.23
-7.17%
18.05.23

Risky Investment
buy
Biogen Inc.

Start price
Target price
Perf. (%)
€204.55
24.09.22
-
24.09.23
37.28%
18.05.23

Risky Investment